75000 - Document - Document and Entity Information
link:presentationLink
link:calculationLink
link:definitionLink
75010 - Statement - Condensed Consolidated Balance Sheets (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75020 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
75030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75040 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) 2
link:presentationLink
link:calculationLink
link:definitionLink
75050 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
75060 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
995455 - Disclosure - Organization and Nature of Operations
link:presentationLink
link:calculationLink
link:definitionLink
995465 - Disclosure - Summary of Significant Accounting Policies
link:presentationLink
link:calculationLink
link:definitionLink
995475 - Disclosure - Prepaid Expenses and Other Current Assets
link:presentationLink
link:calculationLink
link:definitionLink
995485 - Disclosure - Accrued Expenses and Other Current Liabilities
link:presentationLink
link:calculationLink
link:definitionLink
995495 - Disclosure - Short-term Investments
link:presentationLink
link:calculationLink
link:definitionLink
995505 - Disclosure - Debt Facility
link:presentationLink
link:calculationLink
link:definitionLink
995515 - Disclosure - Fair Value Measurements
link:presentationLink
link:calculationLink
link:definitionLink
995525 - Disclosure - Stockholders' Equity
link:presentationLink
link:calculationLink
link:definitionLink
995535 - Disclosure - Commitments and Contingencies
link:presentationLink
link:calculationLink
link:definitionLink
995545 - Disclosure - Stock-Based Compensation
link:presentationLink
link:calculationLink
link:definitionLink
995555 - Disclosure - Segment Reporting
link:presentationLink
link:calculationLink
link:definitionLink
995565 - Disclosure - Net Loss Per Share
link:presentationLink
link:calculationLink
link:definitionLink
995575 - Disclosure - Subsequent Events
link:presentationLink
link:calculationLink
link:definitionLink
995585 - Disclosure - Summary of Significant Accounting Policies (Policies)
link:presentationLink
link:calculationLink
link:definitionLink
995595 - Disclosure - Prepaid Expenses and Other Current Assets (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995605 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995615 - Disclosure - Short-term Investments (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995625 - Disclosure - Debt Facility (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995635 - Disclosure - Fair Value Measurements (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995645 - Disclosure - Stockholders' Equity (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995655 - Disclosure - Commitments and Contingencies (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995665 - Disclosure - Stock-Based Compensation (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995675 - Disclosure - Segment Reporting (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995685 - Disclosure - Net Loss Per Share (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995695 - Disclosure - Organization and Nature of Operations - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995705 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995715 - Disclosure - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995725 - Disclosure - Prepaid Expenses and Other Current Assets - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995735 - Disclosure - Accrued Expenses and Other Current Liabilities - Summary of Accrued Expenses and Other Current Liabilities (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995745 - Disclosure - Short-term Investments - Summary of Major Security and Type of Investments (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995755 - Disclosure - Short-term Investments - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995765 - Disclosure - Debt Facility - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995775 - Disclosure - Debt Facility - Carrying Value and Future Minimum Payments (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995785 - Disclosure - Debt Facility - Carrying Value and Future Minimum Payments (Detail) 2
link:presentationLink
link:calculationLink
link:definitionLink
995795 - Disclosure - Fair Value Measurements - Summary of Fair Value of Financial Instruments (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995805 - Disclosure - Fair Value Measurements - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995815 - Disclosure - Stockholders' Equity - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995825 - Disclosure - Stockholders' Equity - Company's Shares of Common Stock Reserved for Issuance (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995835 - Disclosure - Stockholders' Equity - Summary of Outstanding Warrants for Company's Common Stock (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995845 - Disclosure - Stockholders' Equity - Components of Accumulated Other Comprehensive Loss (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995855 - Disclosure - Commitments and Contingencies - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995865 - Disclosure - Commitments and Contingencies - Schedule of Manufacturing Commitments and Contingencies (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995875 - Disclosure - Stock-Based Compensation - Additional Information (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995885 - Disclosure - Stock-Based Compensation - Summary of Stock-based Awards Activity and RSU Activity (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995895 - Disclosure - Stock-Based Compensation - Stock-based Compensation Expense included in Accompanying Statements of Operations and Comprehensive Loss (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995905 - Disclosure - Segment Reporting - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995915 - Disclosure - Segment Reporting - Summary of Disaggregated Amounts Research and Development Expenses and Segment Net Loss (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995925 - Disclosure - Net Loss Per Share - Schedule of Anti-dilutive Equity Instruments Excluded from Calculation of Diluted Net Loss Per Share (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
995935 - Disclosure - Net Loss Per Share - Reconciles Basic Earnings Per Share and Diluted Earnings Per Share of Common Stock (Detail)
link:presentationLink
link:calculationLink
link:definitionLink
Unamortized end of term charge
Unamortized End Of Term Charge
Unamortized end of term charge.
Tranche 1 [Member]
Tranche 1.
Lease agreement date
Lease agreement date.
Lease Agreement Date
Other Research and Development Expense
Total other research and development expenses
Entity Incorporation, State or Country Code
Entity Incorporation, State or Country Code
Balance Sheet Location
Statement of Financial Position Location, Balance [Domain]
Debt facility
Debt facility
Long-Term Debt, Excluding Current Maturities
Long-term debt
Plan Name
Plan Name [Axis]
Equity [Abstract]
Entity Current Reporting Status
Entity Current Reporting Status
Hercules Capital, Inc. [Member]
Hercules Capital, Inc.
Hercules Capital, Inc. [Member]
Operating expenses:
Operating Expenses [Abstract]
Significant Other Observable Inputs (Level 2) [Member]
Fair Value, Inputs, Level 2 [Member]
Commitments and Contingencies Disclosure [Text Block]
Commitments and Contingencies
Common stock, shares authorized
Common Stock, Shares Authorized
Product and Service
Product and Service [Axis]
Document Fiscal Period Focus
Document Fiscal Period Focus
Liquidity
Liquidity Policy [Text Block]
Liquidity.
Entity Shell Company
Entity Shell Company
Percentage of Achievement of Revenue Milestone
Percentage of achievement of revenue milestone.
Percentage of achievement of revenue milestone
Cash and Cash Equivalents, at Carrying Value, Ending Balance
Cash and Cash Equivalents, at Carrying Value, Beginning Balance
Cash and Cash Equivalents, at Carrying Value, Total
Cash and cash equivalents
Cash and Cash Equivalent
Carrying Value and Future Minimum Payments
Schedule of Maturities of Long-Term Debt [Table Text Block]
Percentage of Sales Forecast
Percentage of sales forecast.
Percentage of sales forecast
Common Stock, Shares, Issued, Total
Common stock, shares issued
Common Stock, Shares, Issued
Statement [Table]
Statement [Table]
2023 Pre-funded Warrants [Member]
Two Thousand and Twenty Three Pre Funded Warrants [Member]
Two thousand and twenty three pre funded warrants.
Statement [Line Items]
Statement [Line Items]
GEMABIOTECH SAU [Member]
GEMABIOTECH SAU.
GEMA [Member]
Warrants to Purchase Common Stock [Member]
Warrant [Member]
Entity Filer Category
Entity Filer Category
Debt Instrument, Redemption, Period Two [Member]
Repayment Occurs After 24 Months and Before 36 Months [Member]
Total liabilities and stockholders’ equity
Liabilities and Equity
Debt Instrument [Line Items]
Debt Instrument [Line Items]
Payables and Accruals [Abstract]
Long-term Debt, Current Maturities, Total
Short-term debt
Long-Term Debt, Current Maturities
Current portion of long-term debt
Current portion of long-term debt
Current portion of long-term debt
Long-Term Debt, Maturity, Year Three
2028
Performance shares potential payout percentage
Performance Shares Potential Payout Percentage
Performance shares potential payout percentage
Prepaid Expenses and Other Current Assets [Member]
Common stock sales agreement, termination date
Common Stock Sales Agreement Termination Date
Common stock sales agreement termination date.
Issuance of stock based awards
Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture
Cash equivalents
Cash and Cash Equivalents, Fair Value Disclosure
Research and development tax credits receivable
Research And Development Tax Credits Receivable
Research and development tax credits receivable.
Stock Options [Member]
Molgramostim Second Source Manufacturer [Member]
Second Source Member
Second source member.
Master services agreement.
Master Services Agreement [Member]
Master Services Agreement [Member]
Borrowing capacity reduction percentage
Borrowing Capacity Reduction Percentage
Percentage of borrowing capacity reduced.
Accounts payable and accrued expenses and other current liabilities
Increase Decrease In Accounts Payable And Accrued Expenses And Other Current Liabilities
Increase decrease in accounts payable and accrued expenses and other current liabilities.
Additional Paid in Capital, Common Stock, Ending Balance
Additional Paid in Capital, Common Stock, Beginning Balance
Additional paid-in capital
Additional Paid in Capital, Common Stock
Debt Instrument, Interest Rate During Period
Debt instrument, interest rate
Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation
Repurchase of shares for minimum tax withholdings
Percentage of Interest after Full Fiscal Quarter Following Achievement of Revenue Milestone
Percentage of interest after full fiscal quarter following achievement of revenue milestone.
Bps reduction in Interest rate after full fiscal quarter following such achievement
Derivative current
Financial Liabilities Fair Value Derivative Current
Financial liabilities fair value derivative current.
Summary of Significant Accounting Policies
Significant Accounting Policies [Text Block]
Deposits and other
Deposits And Other Assets Current
Deposits and other assets current.
Percentage of Unrestricted Cash Required to Maintain Under an Account Control Agreement of Outstanding Principal
Percentage of unrestricted cash required to maintain under an account control agreement of outstanding principal.
Percentage of unrestricted cash required to maintain under an account control agreement of outstanding principal
Vesting [Domain]
Awards granted
Stock Options, Granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Reconciles Basic Earnings Per Share and Diluted Earnings Per Share of Common Stock
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Other Segment Income (Expense), Net
Other segment income (expense), net.
Other segment income (expense), net
Other segment income (expense), net
Awards under Equity Incentive Plan [Member]
Share-Based Payment Arrangement [Member]
Basic
Earnings Per Share, Basic
Earnings Per Share, Basic, Total
Net loss per share, Basic
Repayment of long-term debt
Repayment of outstanding amounts under Loan Agreement
Repayments of Long-Term Debt
Repayments of Long-Term Debt, Total
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Total
Foreign exchange translation adjustment
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax
Gain (loss) on foreign currency translation
Stock Options, Outstanding at beginning balance
Stock Options, Outstanding at ending balance
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Interest Income (Expense), Nonoperating
Interest income, net
Total current liabilities
Liabilities, Current
Adjustments to reconcile net loss to net cash used in operating activities:
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]
Schedule of Manufacturing Commitments and Contingencies
Long-Term Purchase Commitment [Table Text Block]
Schedule of Disaggregated Research and Development Expenses and Segment Net Loss
Schedule Of Disaggregated Research And Development Expenses And Segment Net Loss [Table text block]
Schedule of disaggregated research and development expenses and segment net loss.
Net proceeds after taking into consideration underwriting commissions, legal fees, and other customary closing costs
Net Proceeds After Taking into Consideration Underwriting Commissions, Legal Fees, and Other Customary Closing Costs
Net proceeds after taking into consideration underwriting commissions, legal fees, and other customary closing costs.
Payments of Debt Issuance Costs
Payments of debt issuance costs
Stockholders’ equity:
Equity, Attributable to Parent [Abstract]
Entity Small Business
Entity Small Business
Retained Earnings (Accumulated Deficit), Ending Balance
Retained Earnings (Accumulated Deficit), Beginning Balance
Retained Earnings (Accumulated Deficit), Total
Accumulated deficit
Retained Earnings (Accumulated Deficit)
VAT receivable
Value Added Tax Receivable, Current
Default Penalty Percentage
Default penalty percentage.
Default penalty percentage
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
Stock Options, Expired/cancelled/forfeited
Sale of Stock, Price Per Share
Common stock, sale of stock, price per share
Tranche 2 [Member]
Tranche 2.
Stock-Based Compensation
Share-Based Payment Arrangement [Text Block]
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Estimated service fees, pass through expenses, and investigator fees
Estimated Parexel Service Fees And Pass Through Expenses And Investigator Fees
Estimated parexel service fees and pass through expenses and investigator fees.
Lease Contractual Term [Axis]
Conditional Minimum Revenue Covenant Amount
Conditional minimum revenue covenant amount.
Conditional minimum revenue covenant amount
Loan and Security Agreement [Member]
Loan And Security Agreement [Member]
Loan and security agreement.
Approval Milestone Prior to March15, 2026 [Member]
Approval Milestone Prior to March Fifteen Two Thousand Twenty Six [Member]
Approval Milestone Prior to March Fifteen Two Thousand Twenty Six.
Debt instrument payment description
Debt Instrument, Payment Terms
Amendment Flag
Amendment Flag
Product and Service
Product and Service [Domain]
Exercise Price Two [Member]
Class Of Warrant Two [Member]
Class of warrant two.
Warrants issued
Shares Underlying Outstanding Warrants
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Royalty Purchase and Sale Agreement [Member]
Royalty purchase and sale agreement.
Liabilities and stockholders’ equity
Liabilities and Equity [Abstract]
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Maximum royalty receivable
Maximum Royalty Receivable
Maximum royalty receivable.
Net cash used in operating activities
Cash in operating activities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Tax Credit Income
Tax credit income.
Tax credit income
June 2017 Warrants [Member]
June Two Thousand Seventeen Warrants [Member]
June 2017 warrants.
Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description
Common Stock [Member]
Common Stock [Member]
Long Term Debt Maturities Repayments Of Principal In Next Twelve Months, Total
Long-Term Debt, Maturity, Year One
2026
Schedule Of Available For Sale Securities [Line Items]
Debt Securities, Available-for-Sale [Line Items]
Risks and Uncertainties
Risks And Uncertainties Policy [Text Block]
Risks and uncertainties.
Entity Address, Address Line One
Entity Address, Address Line One
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3
Fair value, assets, transfers out of level 3, amount
Fair Value Hierarchy and NAV
Fair Value Hierarchy and NAV [Axis]
Net loss per share:
Earnings Per Share [Abstract]
Increase (decrease) in carrying value of IPR&D due to foreign currency translation
Increase Decrease In Process Research And Development Due To Foreign Currency Translation
Increase decrease in process research and development due to foreign currency translation.
Supplemental disclosure of cash flow information:
Supplemental Cash Flow Information [Abstract]
Balance Sheet Location
Statement of Financial Position Location, Balance [Axis]
Debt Instrument Maximum Amount to be Drawn
Debt Instrument Maximum Amount to be Drawn
Maximum anount to be drawn
Purchase of available-for-sale securities, net
Payments to Acquire Debt Securities, Available-for-Sale
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax, Total
Unrealized gain (loss) on short-term investments
Debt Instrument, Redemption, Period [Axis]
Class of Warrant or Right
Class of Warrant or Right [Axis]
Document Type
Document Type
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Entity Central Index Key
Entity Central Index Key
Repurchase of shares for minimum tax withholdings.
Repurchase of shares for minimum tax withholdings
Repurchase of shares for minimum tax withholdings
Royalty purchase and sale agreement derivative
Royalty Purchase and Sale Agreement Derivative
Royalty purchase and sale agreement derivative.
Summary of Major Security Type of Investments
Debt Securities, Available-for-Sale [Table Text Block]
Investments, Debt and Equity Securities [Abstract]
Foreign currency loss
Foreign Currency Transaction Loss, before Tax
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Increase in cash and cash equivalents
Subsequent Event Type
Subsequent Event Type [Domain]
Anti-dilutive securities excluded from calculation of diluted net loss per share
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Common stock, par value
Common Stock, Par or Stated Value Per Share
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent, Total
Change
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Operating Lease, Right-of-Use Asset, Periodic Reduction
Reduction in the carrying value of right-of-use assets
Exercise Price Four [Member]
Class Of Warrant Four [Member]
Class of warrant four.
Lease Amendment [Member]
Lease amendment.
Amortized Cost
Debt Securities, Available-for-Sale, Amortized Cost
PARI Pharma GmbH [Member]
PARI Pharma GmbH.
PARI [Member]
Debt Securities, Available-for-sale, Total
Fair Value
Debt Securities, Available-for-Sale
Savara ApS [Member]
Savara Ap S [Member]
Savara ApS.
Stock Options, Exercised
Issuance of common stock upon exercise of stock options, shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Debt Disclosure [Abstract]
Purchase Price Receivable
Purchase price receivable.
Purchase price receivable
Foreign Exchange Translation Adjustment [Member]
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
Development and Manufacturing Service Fees [Member]
Development and Manufacturing Service Fees [Member]
Development and manufacturing service fees.
Accrued Liabilities, Current
Total accrued expenses and other current liabilities
Accrued expenses and other current liabilities
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Current Fiscal Year End Date
Current Fiscal Year End Date
Debt Instrument [Table]
Schedule of Long-Term Debt Instruments [Table]
Document Quarterly Report
Document Quarterly Report
Exercise of Right to the Prepayment
Exercise of right to the prepayment.
Exercise of right to the prepayment
Entity Address, State or Province
Entity Address, State or Province
RSUs, Outstanding at beginning balance
RSUs, Outstanding at ending balance
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Loan commitment drawn
Line of Credit Facility, Remaining Borrowing Capacity
Total comprehensive loss
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Gross Unrealized Gains
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax
Aggregate number of shares of common stock
Total shares reserved
Common Stock, Capital Shares Reserved for Future Issuance
Class of Warrant or Right
Class of Warrant or Right [Domain]
Proceeds from issuance of common stock in registered direct offering net of offering costs.
Proceeds From Issuance Of Common Stock In Registered Direct Offering Net Of Offering Costs
Issuance of common stock in underwritten public offering, net of offering costs
Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation
Repurchase of shares for minimum tax withholdings, shares
Matthew Pauls [Member]
Matthew Pauls.
Stock-based Compensation Expense included in Accompanying Statements of Operations and Comprehensive Loss
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
Issuance of common stock upon exercise of stock options
Stock Issued During Period, Value, Stock Options Exercised
Nature of Expense [Axis]
Subsequent Event [Member]
Subsequent Event [Member]
Change In Fair Value of Royalty Agreement Derivative Liability
Change in fair value of royalty agreement derivative liability.
Change in fair value of royalty agreement derivative liability
Change in fair value of royalty agreement derivative liability
Long-Term Debt, Maturity, Remainder of Fiscal Year
2025
Other Assets, Noncurrent, Total
Other non-current assets
Other Assets, Noncurrent
Debt Securities, Available-for-sale, Current, Total
Short-term investments
Debt Securities, Available-for-Sale, Current
Antidilutive Securities
Antidilutive Securities [Axis]
Sale of available-for-sale securities, net
Proceeds from Sale of Debt Securities, Available-for-Sale
Accumulated Other Comprehensive Income (Loss) [Member]
AOCI Attributable to Parent [Member]
Proceeds from issuance of common stock and pre funded warrants in registered direct offering net of offering costs.
Proceeds From Issuance Of Common Stock And Pre Funded Warrants In Registered Direct Offering Net Of Offering Costs
Issuance of common stock and pre-funded warrants in registered direct offering, net of offering costs
Change of control for payment
Change of Control for Payment
Change of control for payment.
Maturity date
Debt Instrument, Maturity Date
Minimum [Member]
Minimum [Member]
Financial Instrument
Financial Instrument [Axis]
Current assets:
Assets, Current [Abstract]
2021 Inducement Equity Incentive Plan [Member]
Two Thousand Twenty One Inducement Equity Incentive Plan [Member]
Two thousand twenty one inducement equity incentive plan.
Significant Unobservable Inputs (Level 3) [Member]
Fair Value, Inputs, Level 3 [Member]
Segment Reporting [Abstract]
Summary of Fair Value of Financial Instruments
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
Interim Period, Costs Not Allocable [Domain]
Current liabilities:
Liabilities, Current [Abstract]
Product [Member]
Product [Member]
Royalty percent for a calendar year if prior year net sales do not acheive speceified level
Royalty Percent for a Calendar Year if Prior year Net Sales do not Acheive Speceified Level
Royalty percent for a calendar year if prior year net sales do not acheive speceified level.
Two Thousand Twenty Five Performance Share Units [Member]
2025 Performance Share Units.
2025 PSUs [Member]
MOLBREEVI [Member]
MOLBREEVI.
Commitments and Contingencies
Commitments and Contingencies (Note 9)
Change of Control Prior the Closing Date of Royalty Purchase and Sale Agreement
Change of control prior the closing date of royalty purchase and sale agreement.
Change of control prior the closing date of royalty purchase and sale agreement
Active Pharmaceutical Ingredients [Member]
Active Pharmaceutical Ingredients [Member]
Active Pharmaceutical Ingredients.
Accrued general and administrative costs.
Accrued general and administrative costs
Accrued General And Administrative Costs
Amended Loan And Security Agreement [Member]
Amended loan and security agreement.
Amended Loan And Security Agreement [Member]
Payment upon achievement of certain milestones.
Payment Upon Achievement Of Certain Milestones
Achievement of certain milestones related to validation of API supplied by GEMA and regulatory approval of MOLBREEVI drug substance produced at GEMA
Revenue from Contract with Customer, Product and Service [Extensible Enumeration]
Long-Term Debt, Maturity, Year Two
2027
Agreement description
Purchase Commitment, Description
R&D Tax Credit Receivable [Member]
Research And Development Tax Credit Receivable [Member]
Research and development tax credit receivable.
Long-term liabilities:
Liabilities, Noncurrent [Abstract]
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total
Effect of exchange rate changes on cash and cash equivalents
Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation
Net loss
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Lease Contractual Term [Domain]
Long-term Debt, Type
Long-Term Debt, Type [Domain]
Basic
Weighted Average Number of Shares Outstanding, Basic
Weighted Average Number of Shares Outstanding, Basic, Total
Scenario [Axis]
Document Information [Line Items]
Document Information [Line Items]
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Royalty agreement derivative liability
Royalty Agreement Derivative Liability
Royalty agreement derivative liability.
Subsequent Events [Text Block]
Subsequent Events
Total debt
Long-Term Debt
APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total
Stock-based compensation
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
Ending balances
Total stockholders’ equity
Beginning balances
Equity, Attributable to Parent
Basis of Presentation
Basis of Accounting, Policy [Policy Text Block]
Statement of Stockholders' Equity [Abstract]
Royalty percent on net sale
Royalty percent on net sale
Royalty Percent On Net Sale
Royalty percent on net sale.
Use of Estimates
Use of Estimates, Policy [Policy Text Block]
Long-Term Debt, Maturity, Year Five
2030
Foreign Currency Transaction Gain (Loss), before Tax, Total
Gain (Loss), Foreign Currency Transaction, before Tax
Foreign currency exchange gain (loss)
Foreign currency loss
Entity Address, Address Line Two
Entity Address, Address Line Two
Fair Value Measurements
Fair Value Disclosures [Text Block]
Summary of Accrued Expenses and Other Current Liabilities
Schedule of Accrued Liabilities [Table Text Block]
Estimated fees obligation to provide services
Deferred Long-Term Liability Charges
Debt Instrument, Name
Debt Instrument, Name [Domain]
At The Market Offerings [Member]
At the market offerings.
Term Loan [Member]
Term Loan [Member]
Term loan.
Long-Term Debt, Maturity, Year Four
2029
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]
Estimated Service Fees
Estimated Service Fees
Estimated services fees
Plan Name [Domain]
Plan Name
Lease Originally Commencement Date
Lease originally commencement date.
Lease originally commencement date
Estimated Fair Value of Put Option Derivative Liability
Estimated fair value of put option derivative liability.
Estimated fair value of put option derivative liability
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Prepaid Expenses And Other Current Assets [Table]
Prepaid Expenses And Other Current Assets [Table]
Prepaid expenses and other current assets.
Expiration Date
Class Of Warrant Or Rights Expiration Period
Class of warrant or rights expiration period.
Other Non-current Assets [Member]
Other Noncurrent Assets [Member]
Unamortized Discount Related to Warrants
Unamortized Discount related to warrants.
Debt discount related to warrants
Class Of Warrant Or Right [Table]
Class of Warrant or Right [Table]
Entity Address, City or Town
Entity Address, City or Town
Exercise Price One [Member]
Class Of Warrant One [Member]
Class of warrant one.
Number of reportable segments
Number of Reportable Segments
Security Exchange Name
Security Exchange Name
Total future minimum payments
Long-Term Debt, Gross
Counterparty Name
Counterparty Name [Axis]
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Loss before income taxes
Loss before income taxes
Conditional minimum revenue convenant limitation on market capitalization exceeding amount
Conditional Minimum Revenue Convenant Limitation on Market Capitalization Exceeding Amount
Conditional minimum revenue convenant limitation on market capitalization exceeding amount.
Antidilutive Securities, Name
Antidilutive Securities, Name [Domain]
April 2017 Warrants [Member]
April Two Thousand Seventeen Warrants [Member]
April 2017 warrants.
Interest Paid, Excluding Capitalized Interest, Operating Activity
Cash paid for interest
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Statistical Measurement
Statistical Measurement [Domain]
Exercise Price
Class of Warrant or Right, Exercise Price of Warrants or Rights
Total current assets
Assets, Current
Total stock-based compensation
Share-Based Payment Arrangement, Expense
Document Period End Date
Document Period End Date
Other Income and Expenses [Abstract]
Other income, net:
Fair Value Hierarchy and NAV
Fair Value Hierarchy and NAV [Domain]
Common stock shares purchased under stock option plan
Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Purchased for Award
Cash equivalents:
Cash And Cash Equivalents Fair Value Disclosure [Abstract]
Cash and cash equivalents fair value disclosure.
Statement of Financial Position [Abstract]
RSUs [Member]
Issued and nonvested RSUs [Member]
Restricted Stock Units (RSUs) [Member]
Vesting [Axis]
Increase in cash requirement on outstanding principal until approval milestone achieved
Percentage of Increase in Cash Requirement on Outstanding Principal Until Approval Milestone Achieved
Percentage of increase in cash requirement on outstanding principal until approval milestone achieved.
Debt Securities, Available-for-sale, Realized Gain (Loss), Total
Realized gains or losses on investments
Debt Securities, Available-for-Sale, Realized Gain (Loss)
Payroll And Benefits [Member]
Payroll and benefits.
Payroll and Benefits [Member]
Liabilities
Total liabilities
U.S. Government Securities [Member]
US Government Debt Securities [Member]
Financial Instruments
Financial Instruments [Domain]
Percentage of Achieving a Trailing Six Months Net Product Revenue From the Sale of MOLBREEVI
Percentage of achieving a trailing six months net product revenue from the sale of MOLBREEVI.
Percentage of achieving a trailing six months net product revenue from the sale of MOLBREEVI
Deferred financing costs
Deferred Financing Costs Current
Deferred financing costs current.
Commitments And Contingencies [Table]
Commitments And Contingencies [Table]
Commitments and contingencies.
Prepaid Expense and Other Assets, Current [Abstract]
Diluted
Weighted Average Number of Shares Outstanding, Diluted
Weighted Average Number of Shares Outstanding, Diluted, Total
Prepaid Expenses And Other Current Assets [Line Items]
Prepaid Expenses And Other Current Assets [Line Items]
Prepaid expenses and other current assets.
Entity File Number
Securities Act File Number
Unrealized loss on short-term investments
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax
Unrealized loss on short-term investments
Silicon Valley Bank [Member]
Silicon Valley Bank [Member]
Silicon Valley Bank.
Commitments And Contingencies [Line Items]
Commitments And Contingencies [Line Items]
Commitments and contingencies.
Cover [Abstract]
Prepaid Expenses and Other Current Assets
Prepaid Expenses And Other Current Assets [Text Block]
Prepaid expenses and other current assets.
Total prepaid expenses and other current assets
Prepaid expenses and other current assets
Prepaid Expense and Other Assets, Current
RSUs, Forfeited
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Prepayment Penalty Percentage
Prepayment penalty percentage.
Prepayment penalty percentage
Scenario [Domain]
U.S. Treasury Money Market Funds [Member]
US Treasury Securities [Member]
Number of operating segments
Number of Operating Segments
Sale of Stock [Domain]
Segment Reporting
Segment Reporting Disclosure [Text Block]
General and Administrative Expense, Total
General and administrative
General and Administrative Expense
Decrease in cash requirement upon achievement of revenue milestone
Percentage of Decrease in Cash Requirement Upon Achievement of Revenue Milestone
Percentage of decrease in cash requirement upon achievement of revenue milestone.
Extinguishment Of Debt
Gain (Loss) on Extinguishment of Debt
Gain (Loss) on Extinguishment of Debt, Total
Loss on extinguishment of debt
Loss on extinguishment of debt
New Accounting Pronouncements, Policy [Policy Text Block]
Recent Accounting Pronouncements
Former Address [Member]
Former Address [Member]
2008 Stock Option Plan [Member]
Two Thousand And Eight Stock Option Plan [Member]
Two thousand and eight stock option plan.
Proceeds from Issuance of Long-Term Debt
Proceeds from Issuance of Long-Term Debt, Total
Proceeds from long-term debt, net
Common stock, shares outstanding
Common Stock, Shares, Outstanding
Beginning balance, shares
Ending balance, shares
First Amendment [Member]
First Amendment [Member]
First Amendment [Member]
Document Transition Report
Document Transition Report
2024 Omnibus Incentive Option Plan [Member]
Two Thousand Twenty Four Omnibus Incentive Plan [Member]
Two thousand twenty four omnibus incentive plan.
Short-term Investments, Total
Short-term investments
Short-Term Investments
Total operating expenses
Operating Expenses
Revenue Milestone Prior to December 31, 2027 [Member]
Revenue Milestone Prior to December Thirty One Two Thousand Twenty Seven [Member]
Revenue Milestone Prior to December Thirty One Two Thousand Twenty Seven.
Statement of Cash Flows [Abstract]
Issuance of common stock, net
Stock Issued During Period, Value, New Issues
Stockholders' Equity
Equity [Text Block]
Amortized Cost And Fair Value Debt Securities [Abstract]
Amortized cost and fair value debt securities.
Net Loss Per Share
Earnings Per Share [Text Block]
Net loss
Net loss
Long-Term Purchase Commitment, Amount
Total manufacturing and other commitments and contingencies
Purchase Price
Organization And Nature Of Operations [Line Items]
Organization And Nature Of Operations [Line Items]
Organization and nature of operations.
December 2018 Warrants [Member]
December Two Thousand Eighteen Warrants [Member]
December 2018 Warrants.
Earnings Per Share Basic [Line Items]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Assets
Assets [Abstract]
Net Cash Proceeds from Issuance of Equity and Upfront Business Development
Net cash proceeds from issuance of equity and upfront business development.
Net cash proceeds from issuance of equity and upfront business development
Increase (Decrease) in Prepaid Expense and Other Assets, Total
Prepaid expenses and other current assets
Increase (Decrease) in Prepaid Expense and Other Assets
Document Fiscal Year Focus
Document Fiscal Year Focus
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]
Components of Accumulated Other Comprehensive Loss
RTW Investments LP [Member]
RTW Investments, LP.
RTW Investments, LP
RTW Investments, LP [Member]
Cash flows from investing activities:
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]
Accounts Payable, Current, Total
Accounts payable
Accounts Payable, Current
Non-current assets
Increase Decrease In Noncurrent Assets
Increase decrease in noncurrent assets.
Research and Development [Member]
Research and Development Expense [Member]
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]
Short-term Investments
Segment Reporting, Factors Used to Identify Entity's Reportable Segments
Factors used to identify entitys reportable segments
Common stock sales agreement, effective date
Common Stock Sales Agreement Effective Date
Common stock sales agreement effective date.
Minimum Percentage of Agreed Revenue Plan
Minimum percentage of agreed revenue plan.
Percentage of agreed revenue plan
Schedule of Prepaid Expenses and Other Current Assets
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]
Approval Milestone Prior to December Fifteen Two Thousand Twenty Six [Member]
Approval Milestone Prior to December Fifteen Two Thousand Twenty Six.
Approval Milestone Prior to December 15, 2026 [Member]
David Lowrance [Member]
David Lowrance.
Evercore Group L.L.C., [Member]
Evercore [Member]
Evercore Group L L C [Member]
Evercore group llc member.
Proceeds from Stock Options Exercised
Proceeds from exercise of stock options
Fair Value Disclosures [Abstract]
Commitments and Contingencies Disclosure [Abstract]
Net Income (Loss) Available to Common Stockholders, Basic, Total
Net loss attributable to common stockholders
Net Income (Loss) Available to Common Stockholders, Basic
Debt instrument Excess of Threshold Amount to be Drawn
Debt instrument Excess of threshold amount to be drawn.
Debt instrument excess of threshold amount to be drawn
Cash Requirement Limitation on Market Capitalization Exceeding Amount
Cash requirement limitation on market capitalization exceeding amount.
Cash requirement limitation on market capitalization exceeding amount
Additional loan amount
Line of Credit Facility Maximum Borrowing Capacity Additional Borrowing
Line of credit facility maximum borrowing capacity additional borrowing.
Debt Instrument
Debt Instrument [Axis]
Share-Based Payment Arrangement [Abstract]
FujiFilm Diosynth [Member]
FujiFilm diosynth.
Fuji [Member]
Sale of Stock [Axis]
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Net cash provided by investing activities
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3
Fair value, assets, transfers into level 3, amount
Subject to Approval By Lenders Investment Committees [Member]
Subject to Approval By Lenders Investment Committees.
Title of 12(b) Security
Title of 12(b) Security
Schedule of Segment Reporting Information, by Segment [Table]
Occupancy and Other Overhead and Operating Costs [Member]
Occupancy And Other Overhead And Operating Costs [Member]
Occupancy and other overhead and operating costs.
Percentage of Obligation To Pay Closing Fees And Facility Charge
Percentage of Obligation To Pay Closing Fees And Facility Charge
Percentage of obligation to pay closing fees and facility charge
Entity Address, Address Line Three
Entity Address, Address Line Three
Class Of Warrant Or Right [Line Items]
Class of Warrant or Right [Line Items]
Expiration Date
Class Of Warrant Or Rights Expiration Period Description
Class of warrant or rights expiration period description.
Document Information [Table]
Other Liabilities, Noncurrent, Total
Other long-term liabilities
Other Liabilities, Noncurrent
Minimum required maintenance of unrestricted cash
Minimum Required Maintenance of Unrestricted Cash
Minimum required maintenance of unrestricted cash
Debt Instrument, Redemption, Period [Domain]
Consolidated Entities
Consolidated Entities [Axis]
Changes in operating assets and liabilities:
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]
Fair Value, Recurring and Nonrecurring [Table]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Percentage of cancellation fees payable for future services
Percentage of Cancellation Fees Payable for Future Services
Percentage of cancellation fees payable for future services.
Measurement Frequency
Measurement Frequency [Domain]
Income Statement Location
Statement of Income Location, Balance [Axis]
Trading Symbol
Trading Symbol
Debt Instrument, Redemption, Period Three [Member]
Repayment Occurs After 36 months and Before 48 Months [Member]
Subsequent Event Type
Subsequent Event Type [Axis]
Employee-related Liabilities, Current, Total
Accrued compensation
Cash flows from financing activities:
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]
Company's Shares of Common Stock Reserved for Issuance
Schedule Of Common Stock Reserved For Issuance Table [Text Block]
Schedule of common stock reserved for issuance.
Fair Value, Measurements, Recurring [Member]
Fair Value, Recurring [Member]
Accrued Expenses and Other Current Liabilities
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
Savara Australia Pty Limited [Member]
Savara Australia Pty Limited [Member]
Savara australia pty limited.
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent
Equity Components
Equity Components [Axis]
Research and development
Research and Development Expense (Excluding Acquired in Process Cost)
Equity Component
Equity Component [Domain]
Share-Based Payment Arrangement, Activity [Table Text Block]
Summary of Stock-based Awards Activity and RSU Activity
Contingent milestone payments.
Contingent Milestone Payments
Achievement of various development activities and regulatory approval of proprietary nebulizer utilized to administer MOLBREEVI
Address Type [Domain]
Prepaid Insurance
Prepaid insurance
General and administrative expense excluding non-cash stock-based compensation
General and Administrative Expense Excluding noncash Stockbased Compensation
General and administrative expense excluding noncash stockbased compensation.
Prepaid contracted research and development costs
Prepaid Contracted Research And Development Costs
Prepaid contracted research and development costs.
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period
Contractual term
Amount available to sell under equity program
Common Stock Aggregate Offering Price
Common stock aggregate offering price.
Depreciation, Depletion and Amortization, Nonproduction, Total
Depreciation and amortization
Depreciation, Depletion and Amortization, Nonproduction
Maximum [Member]
Maximum [Member]
Entity Addresses, Address Type [Axis]
Statistical Measurement
Statistical Measurement [Axis]
Common Stock, Value, Issued, Ending Balance
Common Stock, Value, Issued, Beginning Balance
Common Stock, Value, Issued, Total
Common Stock, Value, Issued
Common stock, $0.001 par value, 300,000,000 authorized as of March 31, 2026 and December 31, 2025; 204,922,140 and 204,567,283 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively
Net Income (Loss) Available to Common Stockholders, Diluted, Total
Undistributed earnings and net loss attributable to common stockholders, basic and diluted
Net Income (Loss) Available to Common Stockholders, Diluted
Principles of Consolidation
Consolidation, Policy [Policy Text Block]
Class of warrant three.
Exercise Price Three [Member]
Class Of Warrant Three [Member]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Total
Total Accumulated Other Comprehensive Income (Loss)
Total Accumulated Other Comprehensive Income (Loss)
Equity, Including Portion Attributable to Noncontrolling Interest
Lease liability
Accrued Lease Liability
Accrued lease liability.
Amortization of debt issuance costs
Amortization of Debt Issuance Costs
Registered Direct Offering [Member]
Registered direct offering.
2021 Pre-funded Warrants [Member]
Two Thousand And Twenty One Pre Funded Warrants [Member]
2021 Pre funded Warrants.
Two Thousand and Twenty Five Pre Funded Warrants [Member]
Two thousand and twenty five pre funded warrants.
2025 Pre-funded Warrants [Member]
Nebulizer [Member]
Nebulizer [Member]
Nebulizer.
Molbreevi Nebulizer Manufacturer [Member]
Entity Registrant Name
Entity Registrant Name
Adjustment to Additional Paid In Capital Reimbursement of Commissions from Prior Issuance of Common Stock Upon At The Market Sales Net
Adjustment to additional paid in capital reimbursement of commissions from prior issuance of common stock upon at the market sales, net.
Reimbursement of commissions from the prior issuance of common stock upon at the market sales, net
Debt Disclosure [Text Block]
Debt Facility
Gross Unrealized Losses
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax
Total other income, net
Other Nonoperating Income (Expense)
Accumulated Other Comprehensive Income Loss [Table]
Accumulated Other Comprehensive Income (Loss) [Table]
Accrued contracted research and development costs
Accrued Contracted Research And Development Costs
Accrued contracted research and development costs.
Other comprehensive income (loss):
Statement of Other Comprehensive Income [Abstract]
Subsequent Events [Abstract]
Consolidated Entities
Consolidated Entities [Domain]
Income tax benefit
Income Tax Expense (Benefit), Total
Income Tax Expense (Benefit)
Pre-Funded PIPE Warrants [Member]
Pre Funded P I P E Warrants [Member]
Pre-funded PIPE warrants.
Measurement Frequency
Measurement Frequency [Axis]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Concentration Risk, Credit Risk, Policy [Policy Text Block]
Concentration of Credit Risk
Royalty Purchase and Sale Agreement Derivative [Member]
Royalty purchase and sale agreement derivative.
Royalty Purchase and Sale Agreement Derivative [Member]
Reimbursement of commissions from the prior issuance of common stock upon at the market sales, net
Reimbursement Of Commissions From The Prior Issuance Of Common Stock Upon At The Market Sales, Net
Reimbursement of commissions from the prior issuance of common stock upon at the market sales, net.
Accumulated Other Comprehensive Income (Loss), Net of Tax, Total
Accumulated Other Comprehensive Income (Loss), Net of Tax
Accumulated other comprehensive loss
Purchase of property and equipment
Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Property, Plant, and Equipment, Total
RSUs, Granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period
RSUs, Shares Underlying Option Awards, Granted
Total assets
Assets
Income Statement [Abstract]
Debt Instrument, Redemption, Period One [Member]
Repayment Occurs Within 24 months [Member]
Short-term investments:
Short Term Investments Fair Value Disclosure [Abstract]
Short-term investments fair value disclosure.
General and Administrative [Member]
Selling, General and Administrative Expenses [Member]
Common stock, shares sold
Sale of Stock, Number of Shares Issued in Transaction
Debt Instrument, Redemption, Period Four [Member]
Repayment Occurs After 48 Months [Member]
Stock Issued During Period, Shares, New Issues
Issuance of common stock, net, shares
Option to purchase additional shares of common stock
RSUs, Vested
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Issuance of common stock for settlement of RSUs, shares
Diluted
Earnings Per Share, Diluted
Earnings Per Share, Diluted, Total
Net loss per share, Diluted
City Area Code
City Area Code
Nonvested Restricted Shares and Restricted Stock Units [Member]
Nonvested Restricted Shares And Restricted Stock Units [Member]
Nonvested restricted shares and restricted stock units.
Debt fees
Debt Instrument, Fee Amount
Debt Instrument, Face Amount
Initial advance
Line of Credit Facility, Maximum Borrowing Capacity
Loan commitment maximum amount
Counterparty Name
Counterparty Name [Domain]
Segment Reporting Information [Line Items]
Lease Expiration Date
Lease expiration date
Property, Plant and Equipment, Net, Ending Balance
Property, Plant and Equipment, Net, Beginning Balance
Property, Plant and Equipment, Net, Total
Property and equipment, net
Property, Plant and Equipment, Net
Issuance of common stock upon at the market offerings, net
Proceeds From Issuance Of Common Stock Upon At The Market Offerings Net
Proceeds from issuance of common stock upon at the market offerings net.
Issuance of common stock upon at the market offerings, net
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total
Cash and cash equivalents beginning of period
Cash and cash equivalents end of period
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation
Loss from operations
Operating Income (Loss)
Maximum earnings in milestone payment
Maximum Amount Of Earnings In Milestone Payment
Maximum amount of earnings in milestone payment.
Accumulated Deficit [Member]
Retained Earnings [Member]
Share-based Payment Arrangement, Noncash Expense, Total
Stock-based compensation
Share-Based Payment Arrangement, Noncash Expense
Primary program research and development expenses
Research and Development Expense Related Primary Program
Research and development expense related program.
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
Fair Value, Inputs, Level 1 [Member]
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Net cash provided (used in) by financing activities
Summary of Outstanding Warrants for Company's Common Stock
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
Schedule of Anti-dilutive Equity Instruments Excluded from Calculation of Diluted Net Loss Per Share
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Organization And Nature Of Operations [Table]
Organization And Nature Of Operations [Table]
Organization and nature of operations.
Debt Securities, Available-for-Sale [Table]
Entity Interactive Data Current
Entity Interactive Data Current
Income Statement Location
Statement of Income Location, Balance [Domain]
Percentage of cancellation fees.
Percentage of Cancellation Fees
Percentage of cancellation fees
Cash flows from operating activities:
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]
Accretion (Amortization) of Discounts and Premiums, Investments
Accretion on discount to short-term investments
Entity Tax Identification Number
Entity Tax Identification Number
Offering price per share
Share Price
Long-term Debt, Type
Long-Term Debt, Type [Axis]
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale
Maturity of available-for-sale securities
Organization and Nature of Operations
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
R&D tax credit receivable
Prepaid Research And Development Tax Credit Receivable
Prepaid research and development tax credit receivable.
Percentage of Outstanding Principal
Percentage of outstanding principal.
Percentage of outstanding principal
Local Phone Number
Local Phone Number
In-process R&D
In Process Research And Development
In-process research and development.
IPR&D
Accumulated Other Comprehensive Income Loss [Line Items]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Research And Development Operating Costs And Expenses Excluding Non Cash Stock Based Compensation
Research and development operating costs and expenses excluding non cash stock based compensation.
Research and development operating costs and expenses excluding non-cash stock-based compensation
Research and development operating costs and expenses excluding non-cash stock-based compensation
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Total compensation cost not yet recognized
Weighted-average common shares outstanding:
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Accounting Policies [Abstract]
Milestone revenue
Revenue from Contract with Customer, Excluding Assessed Tax, Total
Revenue from inception to date
Revenue from Contract with Customer, Excluding Assessed Tax
Schedule Of Earnings Per Share Basic By Common Class [Table]
Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table]
Unrealized Gain (Loss) on ST Investments [Member]
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]
Common stock shares available for grant
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Weighted-average period to be recognized
Underwritten Offering [Member]
Underwritten offering.
Underwritten Public Offering of Common Stock [Member]
Entity Emerging Growth Company
Entity Emerging Growth Company